What should be the first-choice strategy to maximize posaconazole exposure in daily clinical practice?
- PMID: 19617468
- PMCID: PMC2715631
- DOI: 10.1128/AAC.00256-09
What should be the first-choice strategy to maximize posaconazole exposure in daily clinical practice?
Comment on
-
Pharmacokinetics and absorption of posaconazole oral suspension under various gastric conditions in healthy volunteers.Antimicrob Agents Chemother. 2009 Mar;53(3):958-66. doi: 10.1128/AAC.01034-08. Epub 2008 Dec 15. Antimicrob Agents Chemother. 2009. PMID: 19075045 Free PMC article. Clinical Trial.
References
-
- Alffenaar, J. W., S. van Assen, T. S. van der Werf, J. G. Kosterink, and D. R. Uges. 2009. Omeprazole significantly reduces posaconazole serum trough level. Clin. Infect. Dis. 48:839. - PubMed
-
- Smith, J., and D. Andes. 2008. Therapeutic drug monitoring of antifungals: pharmacokinetic and pharmacodynamic considerations. Ther. Drug Monit. 30:167-172. - PubMed
-
- Walsh, T. J., I. Raad, T. F. Patterson, P. Chandrasekar, G. R. Donowitz, R. Graybill, R. E. Greene, R. Hachem, S. Hadley, R. Herbrecht, A. Langston, A. Louie, P. Ribaud, B. H. Segal, D. A. Stevens, J. A. van Burik, C. S. White, G. Corcoran, J. Gogate, G. Krishna, L. Pedicone, C. Hardalo, and J. R. Perfect. 2007. Treatment of invasive aspergillosis with posaconazole in patients who are refractory to or intolerant of conventional therapy: an externally controlled trial. Clin. Infect. Dis. 44:2-12. - PubMed
-
- Alffenaar, J. W. C., S. van Assen, T. S. van der Werf, J. G. W. Kosterink, and D. R. A. Uges. 2009. Omeprazole significantly reduces posaconazole serum trough level. Clin. Infect. Dis. 48:839. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
